On July 20, Quantinuum rose 5.64% in regular trading, trading at $58.49/share, with turnover of $5.71 million. The stock is recovering toward its $60 IPO price after recent weakness.

On the news front, since multiple top Wall Street investment banks initiated coverage simultaneously on June 29, the stock has experienced persistent wide-range volatility driven by significant valuation divergence. Target prices span from $78 (Morgan Stanley, Equal Weight) to $155 (Rosenblatt, Buy), with JPMorgan at $97 (Overweight), BofA Securities at $100 (Buy), UBS at $93 (Buy), Jefferies at $90 (Buy), Mizuho at $90 (Outperform), and Cantor Fitzgerald at $90 (Overweight). The stock had declined over 5% on both July 16 and July 17 before rebounding today.

Fundamental pressure persists as the company, which listed just over one month ago, reported Q1 revenue declining 73% year-over-year with net losses widening to $136.5 million. Quantinuum is a quantum computing platform company with a vertically integrated system combining quantum hardware, middleware, and application software for real-world deployment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)